Emcure partners with Roche to boost nephrology and transplant care in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
KEYTRUDA had previously met its primary endpoint of progression-free survival in all patients
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
The trial, which compared Retevmo to placebo, met its primary endpoint with a “highly statistically significant and clinically meaningful improvement” in investigator-assessed EFS for patients with stage II–IIIA disease
Profit before tax jumped 64% to Rs. 226 crore, while the company maintained robust investment in innovation with net R&D spend of Rs. 249 crore
Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments
Subscribe To Our Newsletter & Stay Updated